Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Sanjay Gurunathan
Person

Sanjay Gurunathan

Tracked across 1 events · 12 articles · First seen Mar 13, 2026 · Last active Mar 13, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 0
Regulatory
FDA Expands Respiratory syncytial virus vaccine Age Indication
Sanjay Gurunathan, head of Vaccines and Infectious Diseases Research and Development at GSK plc, commented on the significance of the age expansion for Respiratory syncytial virus vaccine, highlighting its potential to address medical needs and ease pressure on the healthcare system.
Mar 13, 2026 · 12 articles
NEWSDESK
Track Sanjay Gurunathan live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.